IPO Boutique

BioAmber IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on BioAmber, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
BioAmberBIOA -
NYSE
$10.00-$12.00 $10.00 $10.008 million5/10/2013
Credit Suisse
Co-Manager(s):
Societe Generale, Barclays, Pacific Crest Securities
Energy
Filing(s):

Filed 2011-11-14
Terms Added 2013-04-11



BioAmber Quote & Chart - Click for current quote - BIOA

About BioAmber (adapted from BioAmber prospectus):
They are a next-generation chemicals company; their technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals.

This description is adapted from BioAmber prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as BioAmber "BIOA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved